These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1592360)

  • 1. Intensive retreatment of adults and children with acute lymphoblastic leukemia.
    Bassan R; Cornelli PE; Battista R; Terzi F; Buelli M; Rambaldi A; Viero P; D'Emilio A; Dini E; Barbui T
    Hematol Oncol; 1992; 10(2):105-10. PubMed ID: 1592360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study.
    Buchanan GR; Boyett JM; Pollock BH; Smith SD; Yanofsky RA; Ghim T; Wharam MD; Crist WM; Vietti TJ; Johnson W
    Cancer; 1991 Jul; 68(1):48-55. PubMed ID: 2049752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia.
    Rivera GK; Hudson MM; Liu Q; Benaim E; Ribeiro RC; Crist WM; Pui CH
    Blood; 1996 Aug; 88(3):831-7. PubMed ID: 8704238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study.
    Buchanan GR; Rivera GK; Pollock BH; Boyett JM; Chauvenet AR; Wagner H; Maybee DA; Crist WM; Pinkel D
    Cancer; 2000 Mar; 88(5):1166-74. PubMed ID: 10699908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group Study.
    Buchanan GR; Rivera GK; Boyett JM; Chauvenet AR; Crist WM; Vietti TJ
    Blood; 1988 Oct; 72(4):1286-92. PubMed ID: 3167209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Larson RA; Dodge RK; Burns CP; Lee EJ; Stone RM; Schulman P; Duggan D; Davey FR; Sobol RE; Frankel SR
    Blood; 1995 Apr; 85(8):2025-37. PubMed ID: 7718875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children.
    Belasco JB; Luery N; Scher C
    Cancer; 1990 Dec; 66(12):2492-7. PubMed ID: 2249189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
    Chiu EK; Chan LC; Liang R; Lie A; Kwong YL; Todd D; Chan TK
    Leukemia; 1994 Sep; 8(9):1469-73. PubMed ID: 8090027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Sadowitz PD; Smith SD; Shuster J; Wharam MD; Buchanan GR; Rivera GK
    Blood; 1993 Feb; 81(3):602-9. PubMed ID: 8427957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
    Ribera JM; Grañena A; Rozman C; Urbano-Ispizua A; Bladé J; Carreras E; Cervantes F; Marín P; Sierra J; Nomdedeu B
    Sangre (Barc); 1990 Feb; 35(1):26-32. PubMed ID: 2333581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
    Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
    Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B.
    Ellison RR; Mick R; Cuttner J; Schiffer CA; Silver RT; Henderson ES; Woliver T; Royston I; Davey FR; Glicksman AS
    J Clin Oncol; 1991 Nov; 9(11):2002-15. PubMed ID: 1941059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia.
    Leahey AM; Bunin NJ; Belasco JB; Meek R; Scher C; Lange BJ
    Med Pediatr Oncol; 2000 May; 34(5):313-8. PubMed ID: 10797352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage therapy for relapsed or refractory childhood acute lymphocytic leukemia by alternative administration a lymphoid- and myeloid-directed chemotherapeutic regimen consisting of dual modulation of ara-C, hydroxyurea, and etoposide.
    Higashigawa M; Hori H; Hirayama M; Kawasaki H; Ido M; Azuma E; Sakurai M
    Leuk Res; 1997 Sep; 21(9):811-5. PubMed ID: 9393595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute lymphoblastic leukemia in a developing country: preliminary results of a nonrandomized clinical trial in El Salvador.
    Bonilla M; Moreno N; Marina N; deReyes G; Shurtleff SA; Downing JR; Behm FG; Harrison PL; Ribeiro RC; Peña O; Crist WM; Antillon FG
    J Pediatr Hematol Oncol; 2000; 22(6):495-501. PubMed ID: 11132215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-directed therapy for childhood acute lymphoblastic leukemia. Results of the Associazione Italiana Ematologia Oncologia Pediatrica '82 studies.
    Vecchi V; Aricò M; Basso G; Ceci A; Madon E; Mandelli F; Masera G; Massimo L; Pession A; Zanesco L
    Cancer; 1993 Oct; 72(8):2517-24. PubMed ID: 8402470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trial of protocol-AL851 for children with high-risk acute lymphoblastic leukemia. Kyushu Yamaguchi Children's Cancer Study Group (KYCCSG)].
    Matsuzaki A; Ishii E; Ueda K; Yanai F; Nibu K; Take H; Koga H; Miyazaki S; Inoue T; Miyake K
    Rinsho Ketsueki; 1994 Sep; 35(9):862-70. PubMed ID: 7967055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-adapted moderate-dose induction and flexible outpatient postremission therapy for elderly patients with acute lymphoblastic leukemia.
    Bassan R; Di Bona E; Lerede T; Pogliani E; Rossi G; D'Emilio A; Buelli M; Rambaldi A; Viero P; Rodeghiero F; Barbui T
    Leuk Lymphoma; 1996 Jul; 22(3-4):295-301. PubMed ID: 8819079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.